Home › Companies › CAPRICOR THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and CAPRICOR THERAPEUTICS INC.’s Form 8-K, filed 2025-05-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore CAPRICOR THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are CAPRICOR THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Frank Litvack, M.D. | 17,272,827 | -- | -- | 795,457 | 12,481,913 | Majority: yes |
| Elect Director: Linda Marbán, Ph.D. | 17,550,630 | -- | -- | 517,654 | 12,481,913 | Majority: yes |
| Elect Director: David B. Musket | 17,409,421 | -- | -- | 658,863 | 12,481,913 | Majority: yes |
| Elect Director: George W. Dunbar, Jr. | 14,964,520 | -- | -- | 3,103,764 | 12,481,913 | Majority: yes |
| Elect Director: Karimah Es Sabar | 10,780,431 | -- | -- | 7,287,853 | 12,481,913 | Majority: yes |
| Elect Director: Paul Auwaerter, M.D. | 17,550,804 | -- | -- | 517,480 | 12,481,913 | Majority: yes |
| Elect Director: Philip Gotwals, Ph.D. | 17,568,301 | -- | -- | 499,983 | 12,481,913 | Majority: yes |
| Elect Director: Michael Kelliher | 17,493,800 | -- | -- | 574,484 | 12,481,913 | Majority: yes |
| Proposal 2: The ratification of the appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder & Jacobs LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025; | 29,548,484 | 563,052 | 438,661 | -- | -- | Majority: yes |
| Proposal 3: To approve the adoption of the Plan; and | 9,673,779 | 8,210,461 | 184,044 | -- | 12,481,913 | Majority: yes |
| Proposal 4: To approve, by non-binding advisory vote, the resolution approving named executive officer compensation. | 16,442,845 | 1,467,438 | 158,001 | -- | 12,481,913 | Majority: yes |
Source: CAPRICOR THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-05-27 — read the filing on EDGAR.
Each item below shows how the 144 asset managers that disclosed a CAPRICOR THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CAPRICOR THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Proposal 4: To approve, by non-binding advisory vote, the resolution approving named executive officer compensation.”): 16,442,845 for, 1,467,438 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 36% for, 3% against (39% of the company cast a for/against vote).
The 143 asset managers below cast 99% of the shares they voted on this item FOR (7,527,734 for, 84,860 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,795,014 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT LLC | 1,564,190 | 0 | 0 | 0 | For |
| State Street | 1,285,440 | 246 | 0 | 0 | For |
| BlackRock | 700,534 | 5,669 | 0 | 0 | For |
| Point72 | 250,520 | 0 | 0 | 0 | For |
| Northern Trust | 197,885 | 0 | 0 | 0 | For |
| Pier Capital, LLC | 188,795 | 0 | 0 | 0 | For |
| Charles Schwab | 183,031 | 0 | 0 | 0 | For |
| PFM Health Sciences, LP | 126,787 | 0 | 0 | 0 | For |
| OPPENHEIMER & CO INC | 123,205 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 101,429 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 88,327 | 0 | 0 | 0 | For |
| Wellington | 80,399 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 67,731 | 0 | 0 | 0 | For |
| Fidelity | 64,037 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,580 | 700 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 46,528 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 32,213 | 0 | 0 | 0 | For |
| Equitable | 27,890 | 0 | 0 | 0 | For |
| UBS | 31 | 27,434 | 0 | 0 | Against |
| Citadel | 23,859 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 23,332 | 0 | 0 | 0 | For |
Showing the 25 largest of 143 asset managers. See all 143 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Frank Litvack, M.D.”): 17,272,827 for, 795,457 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 38% for, 2% withheld (40% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (2,969,701 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,779,557 | 0 | 0 | 0 | For |
| BlackRock | 438,723 | 0 | 0 | 0 | For |
| State Street | 318,432 | 0 | 13 | 0 | For |
| Charles Schwab | 91,481 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Fidelity | 41,454 | 0 | 0 | 0 | For |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 27,890 | 0 | 0 | 0 | For |
| Pacific Life | 12,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 11,448 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,469 | 0 | 0 | 0 | For |
| AQR | 8,037 | 0 | 0 | 0 | For |
| John Hancock | 7,922 | 0 | 0 | 0 | For |
| ProShares | 7,251 | 0 | 0 | 0 | For |
| SEI | 7,200 | 0 | 0 | 0 | For |
| Global X | 5,763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 4,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,035 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 3,832 | 0 | Abstain |
| ALPS ETF Trust | 3,521 | 0 | 0 | 0 | For |
| Brighthouse | 2,989 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 2,468 | 0 | 0 | 0 | For |
| TIAA | 1,738 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: David B. Musket”): 17,409,421 for, 658,863 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 38% for, 1% withheld (40% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (2,973,610 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,779,557 | 0 | 0 | 0 | For |
| BlackRock | 438,723 | 0 | 0 | 0 | For |
| State Street | 318,432 | 0 | 13 | 0 | For |
| Charles Schwab | 91,481 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Fidelity | 41,454 | 0 | 0 | 0 | For |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 27,890 | 0 | 0 | 0 | For |
| Pacific Life | 12,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 11,448 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,469 | 0 | 0 | 0 | For |
| AQR | 8,037 | 0 | 0 | 0 | For |
| John Hancock | 7,922 | 0 | 0 | 0 | For |
| ProShares | 7,251 | 0 | 0 | 0 | For |
| SEI | 7,200 | 0 | 0 | 0 | For |
| Global X | 5,763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 4,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,035 | 0 | 0 | 0 | For |
| Calvert | 3,832 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 3,521 | 0 | 0 | 0 | For |
| Brighthouse | 2,989 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 2,468 | 0 | 0 | 0 | For |
| TIAA | 1,738 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: George W. Dunbar, Jr.”): 14,964,520 for, 3,103,764 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 33% for, 7% withheld (40% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (2,457,794 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,779,557 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 438,723 | 0 | Abstain |
| State Street | 318,432 | 0 | 13 | 0 | For |
| Charles Schwab | 91,481 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Fidelity | 23,155 | 0 | 18,299 | 0 | For |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 13,280 | 0 | 14,610 | 0 | Abstain |
| Pacific Life | 0 | 0 | 12,572 | 0 | Abstain |
| ETFis Series Trust I | 11,448 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 9,469 | 0 | Abstain |
| AQR | 8,037 | 0 | 0 | 0 | For |
| John Hancock | 7,922 | 0 | 0 | 0 | For |
| ProShares | 7,251 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 7,200 | 0 | Abstain |
| Global X | 0 | 0 | 5,763 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 4,048 | 0 | Abstain |
| AIG/SunAmerica | 4,035 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 3,832 | 0 | Abstain |
| ALPS ETF Trust | 3,521 | 0 | 0 | 0 | For |
| Brighthouse | 2,989 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 2,468 | 0 | 0 | 0 | For |
| TIAA | 1,738 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
60% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Karimah Es Sabar”): 10,780,431 for, 7,287,853 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 24% for, 16% withheld (40% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (82,999 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 1,779,557 | 0 | Abstain |
| BlackRock | 0 | 0 | 438,723 | 0 | Abstain |
| State Street | 643 | 0 | 317,802 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 91,481 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 49,532 | 0 | Abstain |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 46,528 | 0 | Abstain |
| Fidelity | 0 | 0 | 41,454 | 0 | Abstain |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 27,890 | 0 | Abstain |
| Pacific Life | 0 | 0 | 12,572 | 0 | Abstain |
| ETFis Series Trust I | 0 | 0 | 11,448 | 0 | Abstain |
| Bridge Builder Trust | 0 | 0 | 9,469 | 0 | Abstain |
| AQR | 0 | 0 | 8,037 | 0 | Abstain |
| John Hancock | 0 | 0 | 7,922 | 0 | Abstain |
| ProShares | 0 | 0 | 7,251 | 0 | Abstain |
| SEI | 0 | 0 | 7,200 | 0 | Abstain |
| Global X | 0 | 0 | 5,763 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 4,048 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 4,035 | 0 | Abstain |
| Calvert | 0 | 0 | 3,832 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 3,521 | 0 | Abstain |
| Brighthouse | 0 | 0 | 2,989 | 0 | Abstain |
| Exchange Place Advisors Trust | 0 | 0 | 2,468 | 0 | Abstain |
| TIAA | 0 | 0 | 1,738 | 0 | Abstain |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Paul Auwaerter, M.D.”): 17,550,804 for, 517,480 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 38% for, 1% withheld (40% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (2,973,814 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,779,557 | 0 | 0 | 0 | For |
| BlackRock | 438,723 | 0 | 0 | 0 | For |
| State Street | 318,445 | 0 | 0 | 0 | For |
| Charles Schwab | 91,481 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Fidelity | 41,454 | 0 | 0 | 0 | For |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 27,890 | 0 | 0 | 0 | For |
| Pacific Life | 12,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 11,448 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,469 | 0 | 0 | 0 | For |
| AQR | 8,037 | 0 | 0 | 0 | For |
| John Hancock | 7,922 | 0 | 0 | 0 | For |
| ProShares | 7,251 | 0 | 0 | 0 | For |
| SEI | 7,200 | 0 | 0 | 0 | For |
| Global X | 5,763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 4,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,035 | 0 | 0 | 0 | For |
| Calvert | 3,832 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 3,521 | 0 | 0 | 0 | For |
| Brighthouse | 2,989 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 2,468 | 0 | 0 | 0 | For |
| TIAA | 1,738 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Philip Gotwals, Ph.D.”): 17,568,301 for, 499,983 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 38% for, 1% withheld (40% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (2,973,814 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,779,557 | 0 | 0 | 0 | For |
| BlackRock | 438,723 | 0 | 0 | 0 | For |
| State Street | 318,445 | 0 | 0 | 0 | For |
| Charles Schwab | 91,481 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Fidelity | 41,454 | 0 | 0 | 0 | For |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 27,890 | 0 | 0 | 0 | For |
| Pacific Life | 12,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 11,448 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,469 | 0 | 0 | 0 | For |
| AQR | 8,037 | 0 | 0 | 0 | For |
| John Hancock | 7,922 | 0 | 0 | 0 | For |
| ProShares | 7,251 | 0 | 0 | 0 | For |
| SEI | 7,200 | 0 | 0 | 0 | For |
| Global X | 5,763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 4,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,035 | 0 | 0 | 0 | For |
| Calvert | 3,832 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 3,521 | 0 | 0 | 0 | For |
| Brighthouse | 2,989 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 2,468 | 0 | 0 | 0 | For |
| TIAA | 1,738 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Kelliher”): 17,493,800 for, 574,484 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 38% for, 1% withheld (40% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (2,973,801 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,779,557 | 0 | 0 | 0 | For |
| BlackRock | 438,723 | 0 | 0 | 0 | For |
| State Street | 318,432 | 0 | 13 | 0 | For |
| Charles Schwab | 91,481 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Fidelity | 41,454 | 0 | 0 | 0 | For |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 27,890 | 0 | 0 | 0 | For |
| Pacific Life | 12,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 11,448 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,469 | 0 | 0 | 0 | For |
| AQR | 8,037 | 0 | 0 | 0 | For |
| John Hancock | 7,922 | 0 | 0 | 0 | For |
| ProShares | 7,251 | 0 | 0 | 0 | For |
| SEI | 7,200 | 0 | 0 | 0 | For |
| Global X | 5,763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 4,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,035 | 0 | 0 | 0 | For |
| Calvert | 3,832 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 3,521 | 0 | 0 | 0 | For |
| Brighthouse | 2,989 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 2,468 | 0 | 0 | 0 | For |
| TIAA | 1,738 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Proposal 2: The ratification of the appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder & Jacobs LLP as the Company's independent registered accounting firm for the fiscal year ending D”): 29,548,484 for, 563,052 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 65% for, 1% against (66% of the company cast a for/against vote).
The 37 asset managers below cast 99.9% of the shares they voted on this item FOR (2,973,801 for, 13 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,779,557 | 0 | 0 | 0 | For |
| BlackRock | 438,723 | 0 | 0 | 0 | For |
| State Street | 318,432 | 13 | 0 | 0 | For |
| Charles Schwab | 91,481 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Fidelity | 41,454 | 0 | 0 | 0 | For |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 27,890 | 0 | 0 | 0 | For |
| Pacific Life | 12,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 11,448 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,469 | 0 | 0 | 0 | For |
| AQR | 8,037 | 0 | 0 | 0 | For |
| John Hancock | 7,922 | 0 | 0 | 0 | For |
| ProShares | 7,251 | 0 | 0 | 0 | For |
| SEI | 7,200 | 0 | 0 | 0 | For |
| Global X | 5,763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 4,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,035 | 0 | 0 | 0 | For |
| Calvert | 3,832 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 3,521 | 0 | 0 | 0 | For |
| Brighthouse | 2,989 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 2,468 | 0 | 0 | 0 | For |
| TIAA | 1,738 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
54.1% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Proposal 3: To approve the adoption of the Plan; and”): 9,673,779 for, 8,210,461 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 21% for, 18% against (39% of the company cast a for/against vote).
The 36 asset managers below cast 0.1% of the shares they voted on this item FOR (789 for, 2,924,436 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 1,779,557 | 0 | 0 | Against |
| BlackRock | 0 | 438,723 | 0 | 0 | Against |
| State Street | 589 | 317,856 | 0 | 0 | Against |
| Charles Schwab | 0 | 91,481 | 0 | 0 | Against |
| Lincoln Financial | 0 | 49,532 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 46,528 | 0 | 0 | Against |
| Fidelity | 0 | 41,454 | 0 | 0 | Against |
| Northern Trust | 0 | 33,567 | 0 | 0 | Against |
| Equitable | 0 | 27,890 | 0 | 0 | Against |
| Pacific Life | 0 | 12,572 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 11,448 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 9,469 | 0 | 0 | Against |
| AQR | 0 | 8,037 | 0 | 0 | Against |
| John Hancock | 0 | 7,922 | 0 | 0 | Against |
| ProShares | 0 | 7,251 | 0 | 0 | Against |
| SEI | 0 | 7,200 | 0 | 0 | Against |
| Global X | 0 | 5,763 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 4,048 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 4,035 | 0 | 0 | Against |
| Calvert | 0 | 3,832 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 3,521 | 0 | 0 | Against |
| Brighthouse | 0 | 2,989 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 0 | 2,468 | 0 | 0 | Against |
| TIAA | 0 | 1,738 | 0 | 0 | Against |
| Nationwide | 0 | 1,300 | 0 | 0 | Against |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Linda Marbán, Ph.D.”): 17,550,630 for, 517,654 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 38% for, 1% withheld (40% of the company cast a for/withheld vote).
The 35 asset managers below cast 100% of the shares they voted on this item FOR (2,970,940 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,779,557 | 0 | 0 | 0 | For |
| BlackRock | 438,723 | 0 | 0 | 0 | For |
| State Street | 318,432 | 0 | 13 | 0 | For |
| Charles Schwab | 91,481 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,532 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,528 | 0 | 0 | 0 | For |
| Fidelity | 41,454 | 0 | 0 | 0 | For |
| Northern Trust | 33,567 | 0 | 0 | 0 | For |
| Equitable | 27,890 | 0 | 0 | 0 | For |
| Pacific Life | 12,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 11,448 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,469 | 0 | 0 | 0 | For |
| AQR | 8,037 | 0 | 0 | 0 | For |
| John Hancock | 7,922 | 0 | 0 | 0 | For |
| ProShares | 7,251 | 0 | 0 | 0 | For |
| SEI | 7,200 | 0 | 0 | 0 | For |
| Global X | 5,763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 4,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,035 | 0 | 0 | 0 | For |
| Calvert | 3,832 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 3,521 | 0 | 0 | 0 | For |
| Brighthouse | 2,989 | 0 | 0 | 0 | For |
| TIAA | 1,738 | 0 | 0 | 0 | For |
| Nationwide | 1,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
54.1% Majority: yes · of votes cast
CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Proposal 3: To approve the adoption of the Plan; and”): 9,673,779 for, 8,210,461 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,676,887 outstanding shares: 21% for, 18% against (39% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (237,393 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Pier Capital, LLC | 188,795 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 48,205 | 0 | 0 | 0 | For |
| Dunham Funds | 393 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (2,861 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Exchange Place Advisors Trust | 2,468 | 0 | 0 | 0 | For |
| Dunham Funds | 393 | 0 | 0 | 0 | For |
Ranked by the number of CAPRICOR THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 45,676,887 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.93% |
| 2 | FARALLON CAPITAL MANAGEMENT LLC | 3.42% |
| 3 | State Street | 2.81% |
| 4 | BlackRock | 1.55% |
| 5 | Point72 | 0.55% |
| 6 | Northern Trust | 0.43% |
| 7 | Pier Capital, LLC | 0.41% |
| 8 | Charles Schwab | 0.40% |
| 9 | PFM Health Sciences, LP | 0.28% |
| 10 | OPPENHEIMER & CO INC | 0.27% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Nippon Shinyaku Co., Ltd. | 15.52% | DEF14A |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.48% | 13G |
| TANG CAPITAL MANAGEMENT, LLC | 7.44% | 13G |
| BlackRock | 6.45% | 13F |
| Highbridge Capital Management, LLC and affiliated entities | 6.11% | DEF14A |
| Vanguard Group | 4.96% | 13F |
| State Street | 4.03% | 13F |
| Linda Marbán, Ph.D. | 3.58% | DEF14A |
| Frank Litvack, M.D. | 2.42% | DEF14A |
| Morgan Stanley | 1.79% | 13F |
Percentages above are of 45,676,887 shares outstanding, as reported by CAPRICOR THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CAPRICOR THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At CAPRICOR THERAPEUTICS INC.'s shareholder meeting held 2025-05-22, in the 2024-2025 proxy season, 144 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,247 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CAPRICOR THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-27.
CAPRICOR THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.